News on book subjects and Eli Lilly
ShareAnalyze the latest news on book subjects and Eli Lilly, extract the entire dataset or get visualizations.
Related dashboards:
Latest news
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Federal officials approve use of Eli Lilly obesity drug Zepbound for treating sleep apnea
The FDA just approved Eli Lilly's Zepbound for sleep apnea -- and Medicare coverage could be next
Eli Lilly weight loss injection drug also helps with obstructive sleep apnea, company says
Promise of Eli Lilly's weight-loss drug for sleep apnea adds another reason to own the stock
Eli Lilly's weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials
Eli Lilly's weight loss drug Zepbound could help treat sleep apnea -- paving a way to Medicare coverage
Eli Lilly's weight-loss drug Zepbound might help cure your sleep apnea
Eli Lilly's weight loss drug Zepbound found to reduce sleep apnea, company says
Extract data
Extract all the news on this scope:
Visualize data
Trend on this scope:
Evolution through time
Source analysis:
Distribution of sources in the news
Section analysis:
Distribution of sections in the news
Current sentiment polarity: slightly positive (0.69)
| positive | 78% | |
| neutral | 22% |
Sentiment polarity through time
